Pre-biopsy prostate-specific antigen velocity does not predict gleason score, tumor location or cancer volume following transperineal-template guided prostate mapping biopsy: Implications for prostate brachytherapy treatment planning

被引：1
|
作者：
Bittner, N. [1 ]
Merrick, G. S. [2 ]
Wallner, K. E. [3 ]
Butler, W. M. [2 ]
Anderson, R. L. [2 ]
Allen, Z. A. [2 ]
Adamovich, E. [4 ]
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Schiffler Canc Ctr, Wheeling, WV USA
[3] Puget Sound Healthcare Corp, Seattle, WA USA
[4] Wheeling Hosp, Dept Pathol, Wheeling, WV USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2008年 / 72卷 / 01期
关键词：
D O I：
10.1016/j.ijrobp.2008.06.1132
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S334 / S334
页数：1
相关论文
共 48 条
  • [1] The Incidence of Transition Zone Prostate Cancer Diagnosed by Transperineal Template Guided Mapping Biopsy: Implications for Treatment Planning
    Patel, V.
    Merrick, G. S.
    Allen, Z. A.
    Butler, W. M.
    Adamovich, E.
    Wallner, K. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S79 - S79
  • [2] Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy: Implications for brachytherapy treatment planning
    Merrick, G. S.
    Gutman, S.
    Adamovich, E.
    Anderson, R.
    Allen, Z.
    Butler, W.
    Wallner, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] Prostate-specific antigen velocity and the odds of detecting gleason 8 to 10 prostate cancer at biopsy.
    D'Amico, A. V.
    Cullen, J.
    Chen, Y.
    McLeod, D. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 233S - 233S
  • [4] The Incidence of Transition Zone Prostate Cancer Diagnosed by Transperineal Template-guided Mapping Biopsy: Implications for Treatment Planning
    Patel, Vareel
    Merrick, Gregory S.
    Allen, Zachariah A.
    Andreini, Hugo
    Taubenslag, Walter
    Singh, Satbir
    Butler, Wayne M.
    Adamovich, Edward
    Bittner, Nathan
    UROLOGY, 2011, 77 (05) : 1148 - 1152
  • [5] Metformin Does Not Predict for Prostate Cancer Diagnosis, Grade, or Volume of Disease After Transperineal Template-guided Mapping Biopsy
    Merrick, Gregory S.
    Bennett, Abbey
    Couture, Travis
    Butler, Wayne M.
    Galbreath, Robert W.
    Adamovich, Edward
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2017, 40 (04): : 353 - 357
  • [6] The Incidence of Transition Zone Prostate Cancer Diagnosed by Transperineal Template-guided Mapping Biopsy: Implications for Treatment Planning COMMENT
    Haas, Gabriel P.
    Delongchamps, Nicolas Barry
    UROLOGY, 2011, 77 (05) : 1153 - 1153
  • [7] Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma
    Stock, RG
    Stone, NN
    DeWyngaert, JK
    Lavagnini, P
    Unger, PD
    CANCER, 1996, 77 (11) : 2386 - 2392
  • [8] An assessment of the usefulness of serum prostate-specific antigen level and cancer volume in biopsy specimens to predict the extent of prostate cancer
    Gohji, K
    Nomi, M
    Kizaki, T
    Morisue, K
    Okamoto, M
    Takenaka, A
    Fujii, A
    BRITISH JOURNAL OF UROLOGY, 1997, 79 (04): : 602 - 607
  • [9] Correction of prostate-specific antigen velocity for variation may improve prediction of cancer following prostate repeat biopsy
    Kumar, Angelish
    Godoy, Guilherme
    Taneja, Samir S.
    CANADIAN JOURNAL OF UROLOGY, 2009, 16 (03) : 4655 - 4659
  • [10] Prediction of extraprostatic extension by prostate specific antigen velocity, endorectal MRI, and biopsy Gleason score in clinically localized prostate cancer
    Nishimoto, Koshiro
    Nakashima, Jun
    Hashiguchi, Akinori
    Kikuchi, Eiji
    Miyajima, Akira
    Nakagawa, Ken
    Ohigashi, Takashi
    Oya, Mototsugu
    Murai, Masaru
    INTERNATIONAL JOURNAL OF UROLOGY, 2008, 15 (06) : 520 - 523
12345